Table 1. Array and MinION sequencing results for a subset of samples from patients who met the case definition for Lassa fever that were positive for virus, Nigeria, 2018 .
| Sample | Kraken hits | TAC virus hits | Mapping hits | Mapped reads, no. (%) |
|---|---|---|---|---|
| 307 | None | None | NA | NA |
| 165 | Human mastadenovirus B | Adenovirus | Adenovirus 2 | 246 (0.07) |
| 349 | Yellow fever virus | Yellow fever virus | Yellow fever virus | 66 (0.02) |
| 370 | None | None | NA | NA |
| 184 | None | None | NA | NA |
| 320 | None | Epstein-Barr virus | Epstein-Barr virus | 22 (0.01) |
| 344 | None | None | NA | NA |
| 279 | Yellow fever | Yellow fever | Yellow fever virus | 72 (0) |
| 157 | Pegivirus C (hepatitis G) | None | Pegivirus C (hepatitis G) | 116 (0.01) |
| 147 | None | Dengue 2 virus | Dengue 2 virus | 0 |
| 322 | None | None | NA | NA |
| 70 | Lassa virus | Lassa virus | Lassa virus | 16309 (5.05)-L, 8265 (2.575)-S |
| 201 | None | None | NA | NA |
*MinION described in (5,6). NA, not applicable; TAC, TaqMan Array Cards (Applied Biosystems, https://www.thermofisher.com).